First Gains on Swine Flu Vaccine Stocks
Posted on: Aug 26th, 2009 | By J. Christoph Amberger | Filed under Financial News
Pre-pandemic profits on Sinovac (AMEX:SVA) Vical Incorporated (NASDAQ:VICL), and Dr. Reddy’s Laboratories (NYSE:RDY)?
Six days ago, on Aug. 20, I sent out our TFN Special Report: The Top Swine Flu Vaccine Stocks under $20. You know the kind of reports I write: Full of useless asides and rambling observations about the vices of the current Administration. In fact, I almost forgot to give you the three free swine flu stock picks I had planned on. That would’ve been a pity because today
Sinovac Biotech Ltd. (AMEX:SVA) is up 30.00%…
Vical Incorporated (NASDAQ:VICL) is up 16.05%…
Even staid-and-steady Indian generics brahmin Dr. Reddy’s Laboratories (NYSE:RDY) is up 3.64%…
No moonshoots, for sure, but 30% in six days beats getting getting your chest waxed. (Or so I’ve heard.)
(The pig flu picks I reserved for our HSC members were a bit smaller… and just a tad more risky. That risk’s been paying off for one stock that shot up over 20% today, for total gains of over 40% in less than a week. But I’m digging in and holding for more..)
Source: First Gains on Swine Flu Vaccine Stocks
Amberger began his career as a freelance contributor to Agora publications before emigrating from Germany to the United States in 1989, when he joined the editorial board of Taipan. In 1991, he took over as managing editor for the publication and assumed responsibility as group publisher four years later. In 2007 Christoph left Taipan and founded TodaysFinancialNews.com along with its premium publications: the highly successful stock Hot Stock Confidential, the options research service TFN Strategic Trader and, most recently, Penny Stock Confidential. In November of 2009, he welcomed Contrarian Profits to the Today's Financial News network. 